1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Human |
Cat.No | ABC-X0245C |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Transfected Stable Cell Lines |
Size/Quantity | 1 vial |
Cell Type | Lymphoblast-like |
Shipping Info | Dry Ice |
Growth Conditions | 37 °C, 5% CO2 |
Source Organ | Blood |
Disease | Acute Myeloid Leukemia |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Overexpression Stable Cell Lines |
Host Cell | MOLM-13 |
AXL MOLM-13 Overexpression Cell Line is a genetically engineered model derived from the MOLM-13 acute myeloid leukemia cell line, tailored to customer requirements. AXL MOLM-13 overexpression cell line is generated by stable integration of exogenous human AXL into host cells via optimized lentiviral transduction. Overexpression clone is validated at gene level by qRT-PCR.
Target
The AXL gene encodes a receptor tyrosine kinase involved in cell survival, proliferation, and immune modulation via the PI3K/AKT and MAPK pathways. Its overexpression is associated with therapy resistance and poor prognosis in leukemia, non-small cell lung cancer, and breast cancer. AXL is a critical mediator of epithelial-to-mesenchymal transition and immune evasion. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.
For research use only